Repligen (RGEN) Other Operating Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Other Operating Expenses data on file, last reported at -$13.8 million in Q1 2026.

• Quarterly Other Operating Expenses changed N/A year-over-year to -$13.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.2 million (down 14.09% YoY) and the FY2025 annual result came in at $338.4 million, down 6.77% from the prior year.
• Other Operating Expenses fell to -$13.8 million in Q1 2026 per RGEN's latest filing, from $92.6 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $131.9 million in Q4 2024 and bottomed at -$13.8 million in Q1 2026.
• The 5-year median for Other Operating Expenses is $80.5 million (2022), against an average of $78.1 million.
• The widest annual swing landed in 2024, when Other Operating Expenses surged 48.48%; it then slipped 29.82% in 2025.
• Tracing RGEN's Other Operating Expenses over 5 years: stood at $73.6 million in 2022, then gained by 20.74% to $88.8 million in 2023, then jumped by 48.48% to $131.9 million in 2024, then retreated by 29.82% to $92.6 million in 2025, then sank by 114.87% to -$13.8 million in 2026.
• Per Business Quant, the three latest RGEN Other Operating Expenses figures stand at -$13.8 million (Q1 2026), $92.6 million (Q4 2025), and $84.1 million (Q3 2025).

Peer Comparison